A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy
Condition(s):B Cell LymphomaLast Updated:July 29, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):B Cell LymphomaLast Updated:July 29, 2019Unknown status
Condition(s):B-cell LymphomaLast Updated:September 4, 2020Terminated
Condition(s):B-cell LymphomaLast Updated:October 11, 2018Terminated
Condition(s):B Cell LymphomasLast Updated:March 23, 2021Withdrawn
Condition(s):B-Cell LymphomaLast Updated:May 18, 2022Completed
Condition(s):Large B-cell LymphomaLast Updated:January 26, 2022Recruiting
Condition(s):B-Cell LymphomaLast Updated:March 28, 2012Completed
Condition(s):B-cell LymphomaLast Updated:March 8, 2022Completed
Condition(s):B-cell LymphomaLast Updated:March 6, 2023Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:December 23, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.